首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

市場調查報告書

商品編碼

1532363

腦膜炎雙球菌疫苗市場：按類型、銷售管道、年齡層、地區分類

Meningococcal Vaccines Market, By Type, By Sales Channel, By Age Group, By Geography

出版日期: 2024年06月28日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球腦膜炎雙球菌疫苗市場規模為41億美元，預計2031年將達81.1億美元，2024年至2031年複合年成長率為10.2%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	41億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	10.20%	2031年價值預測	81.1億美元

圖：2024 年按地區分類的腦膜炎雙球菌疫苗市場佔有率(%)

腦膜炎球菌病菌感染是一種引起腦膜炎和敗血症的細菌感染疾病，如果不及時治療，可能會導致嚴重甚至死亡。侵襲性腦膜炎雙球菌疾病的盛行率不斷上升，加上人們越來越認知到可以針對此類感染疾病提供有效的疫苗，因此全球對腦膜炎雙球菌疫苗的需求可能會增加。此外，針對新血清型的結合疫苗的持續研究和開發以及疫苗接種計劃在全球範圍內的擴展可以在不久的將來為市場相關人員提供許多機會。然而，疫苗開發相關的高成本和替代品的威脅等因素可能會阻礙市場成長。

市場動態：

全球腦膜炎球菌疫苗市場的成長動力是由於人口和生活方式的變化，全球侵襲性腦膜炎球菌病患疾病率不斷上升。根據世界衛生組織 (WHO) 統計，全世界每年約有 120 萬例流行性腦膜炎雙球菌性腦膜炎病例，約 135,000 人死亡。各國政府和衛生組織擴大採取舉措，透過國家免疫計劃促進針對主要血清型的免疫計劃，這正在推動腦膜炎球菌疫苗的使用。新一代多效價腦膜炎雙球菌疫苗的推出可提供對新血清群的保護，為市場進入者提供了機會。然而，與開發新型腦膜炎雙球菌疫苗相關的高昂研發成本以及替代治療方案的可用性可能會阻礙市場成長。

本研究的主要特點

本報告對全球腦膜炎球菌疫苗市場進行了詳細分析，包括年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球腦膜炎雙球菌疫苗市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球腦膜炎雙球菌疫苗市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球腦膜炎雙球菌疫苗市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- GlaxoSmithKline plc
- Pfizer Inc.
- Sanofi Pasteur
- Merck &Co., Inc.
- Serum Institute of India Pvt. Ltd.
- Walvax Biotechnology Co., Ltd.
- Hualan Biological Engineering Inc.
- JN-International Medical Corporation
- Beijing Minhai Biotechnology Co., Ltd
- Bio-Manguinhos/Fiocruz
- Chongqing Zhifei Biological Products Co., Ltd.
- Baxter International
- CSL Limited
- Bavarian Nordic
- Incepta Vaccine Ltd.
- Sinovac Biotech Ltd.
- Novartis
- Panacea Biotec Ltd

第10章分析師建議

命運之輪
分析師觀點
一致的機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI3864

Global meningococcal vaccines market is estimated to be valued at USD 4.10 Bn in 2024 and is expected to reach USD 8.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 4.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	10.20%	2031 Value Projection:	US$ 8.11 Bn

Figure. Meningococcal Vaccines Market Share (%), By Region 2024

Meningococcal disease refers to the bacterial infections causing meningitis and sepsis that can lead to serious illness or even death, if not promptly treated. Rising prevalence of these invasive meningococcal diseases along with growing awareness about the availability of effective vaccines against such infections can boost demand for meningococcal vaccines globally. Furthermore, ongoing research & development activities for new conjugate vaccines against additional serotypes and expanding vaccination programs worldwide can offer numerous opportunities for market players in the near future. However, factors such as high costs associated with vaccine development and threats of substitutes can hamper the market growth.

Market Dynamics:

Global meningococcal vaccines market growth is driven by rising prevalence of invasive meningococcal diseases worldwide due to changing demographics and lifestyle patterns. According to the World Health Organization (WHO), approximately 1.2 million cases of meningococcal meningitis occur every year across the globe, leading to around 135,000 deaths. Growing initiatives by governments and health agencies to promote immunization programs against major serotypes through national vaccination schedules boosts uptake of meningococcal vaccines. Introduction of newer generation multivalent meningococcal vaccines providing protection against additional serogroups can offer opportunities for market players. However, high research and development costs associated with development of novel meningococcal vaccines along with availability of alternative treatment options can hamper the market growth.

Key Features of the Study:

This report provides in-depth analysis of the global meningococcal vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global meningococcal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi SA, Pfizer Inc., Merck & Co., Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global meningococcal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningococcal vaccines market

Detailed Segmentation-

By Type
- Polysaccharide Vaccines
- Conjugate Vaccines
- Combination Vaccines
- Other
By Sales Channel
- Public
- Private
By Age Group
- Infants (0 to 2 years)
- Children and Adults (2 years & above)
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- GlaxoSmithKline plc
- Pfizer Inc.
- Sanofi Pasteur
- Merck & Co., Inc.
- Serum Institute of India Pvt. Ltd.
- Walvax Biotechnology Co., Ltd.
- Hualan Biological Engineering Inc.
- JN-International Medical Corporation
- Beijing Minhai Biotechnology Co., Ltd
- Bio-Manguinhos/Fiocruz
- Chongqing Zhifei Biological Products Co., Ltd.
- Baxter International
- CSL Limited
- Bavarian Nordic
- Incepta Vaccine Ltd.
- Sinovac Biotech Ltd.
- Novartis
- Panacea Biotec Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Sales Channel
- Market Snapshot, By Age Group
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Meningococcal Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Meningococcal Vaccines Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Polysaccharide Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Conjugate Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Combination Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Meningococcal Vaccines Market, By Sales Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Meningococcal Vaccines Market, By Age Group, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Infants (0 to 2 years)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Children and Adults (2 years & above)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Meningococcal Vaccines Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline plc
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi Pasteur
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Walvax Biotechnology Co., Ltd.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hualan Biological Engineering Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- JN-International Medical Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Beijing Minhai Biotechnology Co., Ltd
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio-Manguinhos/Fiocruz
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Chongqing Zhifei Biological Products Co., Ltd.
- Baxter International
- CSL Limited
- Bavarian Nordic
- Incepta Vaccine Ltd.
- Sinovac Biotech Ltd.
- Novartis
- Panacea Biotec Ltd